HEATHER SPENGLER: Open Payments
NPI 1780379859 · COLLEYVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,713 in 73 payments from 21 companies in 2025. Trend: 2023 $534 · 2024 $866 · 2025 $1,713
Food & beverage: $1,713
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 13 | $383 |
| Axsome Therapeutics, Inc. | 5 | $217 |
| Janssen Pharmaceuticals, Inc | 5 | $206 |
| ABBVIE INC. | 14 | $193 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $88 |
| Otsuka America Pharmaceutical, Inc. | 4 | $77 |
| E.R. Squibb & Sons, L.L.C. | 4 | $71 |
| Corium, LLC | 2 | $66 |
| Alkermes, Inc. | 3 | $62 |
| Lundbeck LLC | 3 | $54 |
Products named: INGREZZA, Auvelity, VRAYLAR, INVEGA SUSTENNA, REXULTI, CAPLYTA, COBENFY, Azstarys.
Industry payments across TX — which companies pay providers there.
